Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001388597 | SCV001589651 | pathogenic | Primary pulmonary hypertension | 2021-08-23 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg381Lysfs*18) in the BMPR2 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with pulmonary arterial hypertension (PMID: 19206171). ClinVar contains an entry for this variant (Variation ID: 425880). Loss-of-function variants in BMPR2 are known to be pathogenic (PMID: 16429395). For these reasons, this variant has been classified as Pathogenic. |
Rare Disease Genomics Group, |
RCV000488632 | SCV000576173 | pathogenic | Pulmonary hypertension, primary, 1 | no assertion criteria provided | literature only |